Kurt Graves is the founder of i2o Therapeutics. i2o Therapeutics has raised $46M in total funding. Latest round: Series A. Based in Boston, USA.
Kurt Graves is the CEO of i2o Therapeutics, a company based in Cambridge/Allston, Massachusetts. The company develops oral biologics and peptides using proprietary ionic liquids to treat metabolic and inflammatory diseases. i2o Therapeutics secured $46 million in Series A funding and acquired assets from Intarcia Therapeutics, including the Medici™ osmotic implant system. The company leverages a four-year research and licensing deal with co-founder Samir Mitragotri's Harvard lab to advance its drug delivery platforms.
Full founder directory · Investor directory · Company funding database · Fundraising library